Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	16.60	24.49	21.01
Graham Fair Price	5.89	1.69	1.59
PEG	116.49	1.00	0.46
Price/Book	26.40	4.02	3.18
Price/Cash Flow	-58.11	29.50	70.41
Prices/Earnings	22.75	9.09	7.40
Price/Sales	26.96	2.35	1.85
Price/FCF	-58.11	29.50	70.41
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-12.69	0.12	0.14
Operating Margin	-9.94	0.08	0.09
ROA	8.11	0.05	0.05
ROE	0.11	0.11	2.98
ROIC	0.08	0.09	10.25
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	-0.23	-0.14	-60.89
Dividends QOQ	0.00	0.80	100.00
EBIT QOQ	0.26	-0.02	-90.49
EPS QOQ	0.16	0.09	-43.30
FCF QOQ	0.00	2.28	100.00
Revenue QOQ	0.00	0.08	100.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.89	0.88	-69.54
Days Sales Outstanding (DSO)	45.52	49.10	7.85
Inventory Turnover	31.16	102.30	228.35
Debt/Capitalization	0.33	0.26	-21.56
Quick Ratio	1.10	1.43	30.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	1.03	1.07	4.35
Cash	0.38	0.35	-8.00
Capex	< 0.005	-0.01	-25.96
Free Cash Flow	0.05	0.15	214.85
Revenue	1.76	1.83	3.89
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.14	1.44	26.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.83	0.17	-79.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating